PatientsVille.com Logo

DEAFNESS and Levitra

PatientsVille

DEAFNESS Symptoms and Causes

It's frustrating to be unable to hear well enough to enjoy talking with friends or family. Hearing disorders make it hard, but not impossible, to hear. They can often be helped. Deafness can keep you from hearing sound at all.

What causes hearing loss? Some possibilities are

  • Heredity
  • Diseases such as ear infections and meningitis
  • Trauma
  • Certain medicines
  • Long-term exposure to loud noise
  • Aging

There are two main types of hearing loss. One happens when your inner ear or auditory nerve is damaged. This type is usually permanent. The other kind happens when sound waves cannot reach your inner ear. Earwax build-up, fluid, or a punctured eardrum can cause it. Treatment or surgery can often reverse this kind of hearing loss.

Untreated, hearing problems can get worse. If you have trouble hearing, you can get help. Possible treatments include hearing aids, cochlear implants, special training, certain medicines, and surgery.

NIH: National Institute on Deafness and Other Communication Disorders

Check out the latest treatments for DEAFNESS

DEAFNESS treatment research studies

Levitra clinical trials, surveys and public health registries


Find Drug Side Effect reports



Levitra Side Effects

Erectile Dysfunction (899)
Headache (338)
Flushing (154)
Dizziness (121)
Nasal Congestion (104)
Vision Blurred (101)
Erection Increased (87)
Adverse Event (67)
Visual Disturbance (60)
Nausea (60)
Visual Acuity Reduced (51)
Chest Pain (47)
Feeling Abnormal (45)
Optic Ischaemic Neuropathy (44)
Dyspnoea (40)
Deafness Unilateral (38)
Visual Field Defect (36)
Dyspepsia (35)
Loss Of Consciousness (35)
Tinnitus (33)
Eye Pain (33)
Eye Disorder (33)
Cerebrovascular Accident (33)
Diarrhoea (30)
Heart Rate Increased (30)
Hypotension (29)
Blood Pressure Decreased (29)
Photopsia (27)
Feeling Hot (26)
Myocardial Infarction (26)
Vomiting (25)
Penile Pain (25)
Fatigue (24)
Ejaculation Failure (24)
Back Pain (23)
Asthenia (23)
Hypertension (23)
Visual Impairment (22)
Rhinorrhoea (22)
Ocular Hyperaemia (22)
Chest Discomfort (21)
Palpitations (21)
Penis Disorder (21)
Photophobia (21)
Ejaculation Disorder (20)
Chills (20)
Erythema (20)
No Adverse Event (20)
Transient Ischaemic Attack (20)
Fall (20)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

DEAFNESS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Outcomes In Children With Developmental Delay And Deafness
Conditions: Deafness;   Hearing Loss
Interventions: Device: cochlear implantation;   Device: hearing aids
Outcome Measures: auditory development;   Linguistic development;   Cognitive development;   Quality of life
2 Not yet recruiting Comparison of BAHA and CROS Hearing Aid in Single-Sided Deafness
Conditions: Unilateral Hearing Loss;   Unilateral Deafness
Intervention: Device: CROS hearing aid
Outcome Measures: Change in Speech-in-noise (QuickSIN) test scores;   Bern Benefit in Single-Sided Deafness Questionnaire (BBSS);   Speech Spatial Qualities Questionnaire (SSQ)
3 Recruiting Prevalence of POU4F3 and SLC17A8 Mutations
Condition: Genetic Deafness
Intervention: Genetic: SLC17A8 et POU4F3 mutations genes analysis
Outcome Measures: SLC17A8 et POU4F3 mutations genes analysis;   Phenotypic characterization of the carrier patients
4 Not yet recruiting Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Condition: Single Sided Deafness
Intervention: Device: SoundBite
Outcome Measures: APHAB Questionnaire;   Single Sided Deafness Questionnaire
5 Recruiting Clinical Study of Cochlear Implants in Adults With Asymmetrical Hearing Loss
Condition: Hearing Loss
Intervention: Procedure: Cochlear Implantation
Outcome Measures: Sound localization using a 140 degree, horizontal plane loudspeaker arc;   Speech recognition;   Perceived benefit questionnaire
6 Not yet recruiting Prevention of Noise-induced Hearing Loss
Condition: Noise-induced Hearing Loss
Interventions: Drug: Zonisamide;   Drug: Methylprednisolone
Outcome Measures: Pure Tone Thresholds;   DPOAE;   Pure tone thresholds
7 Recruiting Single-sided Deafness and Cochlear Implants
Condition: Sensorineural Hearing Loss (Disorder)
Intervention: Device: cochlear implant
Outcome Measures: Audiometry;   PET scan
8 Not yet recruiting Long QT and Hearing Loss Registry
Conditions: Sensorineural Hearing Loss;   Long QT Syndrome
Intervention:
Outcome Measures: The incidence of an abnormal ECG (QTc > 450) in neonates greater than a week of age with either unilateral or bilateral sensorineural hearing loss;   In neonates > 1 week of age with either bilateral or unilateral sensorineural hearing loss and an abnormal ECG, percentage have an identifiable genetic mutation
9 Recruiting Assessment of Age-related Hearing Loss in HIV-1 Patients
Condition: HIV Seropositivity
Intervention:
Outcome Measures: hearing loss at several frequencies;   threshold for speech intelligibility;   Proportion of patients with neuropathic hearing loss;   Interval I-V on the evoked-response audiogram;   Maximum speech intelligibility;   Proportion of patients with age-related hearing loss
10 Recruiting Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators
Condition: Congenital Hearing Loss
Interventions: Behavioral: Patient Navigator;   Behavioral: Standard scheduling and follow-up
Outcome Measures: Number of participants who do not receive diagnostic audiological testing (Aim 1);   Number of participants who do not receive hearing intervention by six months of age (Aim 2);   Number of weeks between birth and date of diagnostic audiological testing (Aim 1);   Number of weeks between date of hearing loss diagnosis and intervention (Aim 2)
11 Not yet recruiting SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Conditions: Lung Cancer;   Head and Neck Cancer;   Hearing Loss;   Ototoxicity;   Tinnitus;   Neuropathy
Interventions: Drug: SPI-1005 Low Dose;   Drug: SPI-1005 Middle Dose;   Drug: SPI-1005 High Dose;   Drug: Placebo
Outcome Measures: Number of participants with adverse events;   Reduction of hearing loss incidence and severity;   Reduction of tinnitus incidence and severity.
12 Unknown  Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation
Condition: Hearing Loss
Intervention: Drug: Proton pump inhibitor
Outcome Measure: Decrease in attack frequency or improvement of hearing loss
13 Recruiting Natural History and Genetic Studies of Usher Syndrome
Conditions: Retinitis Pigmentosa Syndromic;   Congenital Deafness;   Usher Syndrome;   Retinitis Pigmentosa and Deafness;   Progressive Hearing Loss;   Retinitis Pigmentosa
Intervention:
Outcome Measure:
14 Recruiting Non-Syndrome Hereditary Hearing Impairment - Gene Mapping: India/Pakistan Protocol
Condition: Hearing Impairment
Intervention:
Outcome Measure:
15 Recruiting Maximizing Language Development in Children With Hearing Loss
Condition: Hearing Loss
Intervention: Behavioral: Early language intervention
Outcome Measures: MacArthur Communicative Development Inventories;   Preschool Language Scale
16 Unknown  Fludrocortisone for Sudden Hearing Loss
Condition: Hearing Loss, Sensorineural
Intervention: Drug: Fludrocortisone
Outcome Measure: Hearing
17 Recruiting Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Conditions: Hearing Loss;   Deafness;   Hearing Loss, Sensorineural;   Hearing Disorders;   Ear Diseases
Interventions: Drug: Ancrod;   Drug: Saline solution
Outcome Measures: Change in PTA (pure tone audiogram) in the affected ear;   Change in speech recognition in the affected ear
18 Recruiting Phase 3 Clinical Trial: D-Methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Condition: Noise-Induced Hearing Loss
Interventions: Drug: D-methionine, oral liquid suspension;   Other: Placebo Comparator
Outcome Measures: Pure tone air conduction threshold;   Tinnitus scales
19 Not yet recruiting Sudden Hearing Loss Multi-center Clinical Trial
Condition: Full-frequency Sudden Hearing Loss
Interventions: Drug: Dexamethasone Phosphate;   Drug: Ginaton
Outcome Measures: Pure tone audiometry test;   Tinnitus with Evaluation questionnaire;   Vertigo with Evaluation questionnaire
20 Unknown  Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment
Condition: Cisplatin Ototoxicity
Intervention: Drug: Dexamethasone Phosphate
Outcome Measure: Examine possible protective effect of IT dexamethasone on cisplatin-induced hearing loss. Hearing assessment would include:pure tone, speech and impedance audiometry, and Distortion Product Otoacoustic Emissions (DPOAEs) testing.